APA (7th ed.) Citation

Kaplan, A., Young, J. H., Kandaswamy, R., Berglund, D., Knoll, B. M., Sieger, G., . . . Obeid, K. M. (2020). Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients. Canadian Journal of Infectious Diseases & Medical Microbiology, 1. https://doi.org/10.1155/2020/8883183

Chicago Style (17th ed.) Citation

Kaplan, Adam, Jo-Anne H. Young, Raja Kandaswamy, Danielle Berglund, Bettina M. Knoll, Gretchen Sieger, Winston Cavert, Arthur Matas, and Karam M. Obeid. "Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients." Canadian Journal of Infectious Diseases & Medical Microbiology 2020: 1. https://doi.org/10.1155/2020/8883183.

MLA (9th ed.) Citation

Kaplan, Adam, et al. "Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients." Canadian Journal of Infectious Diseases & Medical Microbiology, 2020, p. 1, https://doi.org/10.1155/2020/8883183.